As Lilly’s Realized Sales Prices Drop, Ricks Reiterates Criticism Of US Drug Price Plan

 
• By Joseph Haas

With Lilly’s sales narrative hampered by global price pressures, Lilly CEO David Ricks again criticized drug price negotiation proposals before Congress. Mounjaro launch offers a bright spot, exceeding projections.

Lilly's-Biotechnology-Center-San-Diego
At Lilly, sales volume is up but revenue is down

More from Earnings

More from Business